Researchers at Stanford University uncover TEM beta-lactamase enzyme’s evolution from changing electric fields and resisting antibiotics. During the Biophysical Society's 62nd Annual Meeting, held Feb ...

Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Astellas Pharma Inc., Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Meiji ...

The Beta-lactam and Beta-lactamase Inhibitors Market encompasses a wide range of antibiotics and enzyme inhibitors used in the treatment of various bacterial infections. Beta-lactams are a class of ...

Roche licenses investigational beta-lactamase inhibitor OP0595 OP0595 targets beta-lactamase enzymes in combination with new or existing beta-lactam antibiotics to enhance their effectiveness in ...

Developing chemicals to slow down an enzyme that provides multi-resistance to antibiotics may be the key to reverse antibiotic resistance. Developing chemicals to slow down an enzyme that provides ...

Antibiotics is an antimicrobial substance or a compound that fights against bacterial infections and sometimes with protozoan infections but not viral infections. Antibiotics are the medications that ...

Eucodis Bioscience, a company developing enzymes for the chemical, the pharmaceutical and other industries, has successfully launched its first commercial enzyme, a beta-lactamase. The product is ...

Antibiotic treatment disrupts the balance of beneficial and harmful bacteria in a person's gut. That disruption can lead to the overgrowth of fungal species in the gut mycobiota, including the common ...

Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Astellas Pharma Inc., Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Meiji ...